TP53 and cancer: Given that our previous prospective data suggest the positive predictive value of Cytosponge p53 and/or atypia was 31% for a diagnosis of dysplasia or cancer, this suggests that around 4% of TFF3-positive individuals undergoing surveillance have dysplasia or cancer, in line with what would be expected.22